Prasugrel
- OralPrasugrelEffientA prodrug that requires enzymatic activation
Mechanism of Action
- Irreversibly inhibits the binding of adenosine diphosphate (ADP) to platelet P2Y₁₂ receptors, resulting in reduced platelet activation and aggregation.
Pharmacology
- A pro-drug that requires enzymatic activation.
Clinical Use
- Indications
- Acute coronary syndrome (in conjunction with aspirin)
- Prevention of in-stent thrombosis following percutaneous coronary intervention
- Contraindications
- Active bleeding
- Intracranial haemorrhage
Adverse Effects
- Haemorrhage.
